Development and temporal validation of a practical prognostic scoring system (ONCOGERIATRIC INDEX -OGI) based on the comprehensive geriatric assessment to predict early death in elderly cancer patients: A 892 patients cohort study.

Authors

Jurema Telles O Lima

Jurema Telles O Lima

IMIP - Instituto de Medicina Integral Professor Fernando Figueira, Recife, PE, Brazil

Jurema Telles O Lima , Mirella Rebello Bezerra , Maria Julia Gonçalves Mello , José Natal Figueiroa , Anke Bergmann , Zilda Cavalcanti , Raissa Viana , Letícia telles Sales , Luiz Claudio Santos Thuler

Organizations

IMIP - Instituto de Medicina Integral Professor Fernando Figueira, Recife, PE, Brazil, Instituto De Medicina Integral Prof. Fernando Figueira, Recife, Brazil, Instituto de Medicina Integral Prof. Fernando Figueira - IMIP, Recife, Brazil, IMIP - Instituto de Medicina Integral Professor Fernando Figueira, Recife, Brazil, Brazilian National Cancer Institute, Rio De Janeiro, Brazil, imip, Recife, Brazil, Brazilian National Cancer Institute, Rio de Janeiro, Brazil

Research Funding

Other

Background: Recognizing prognostic factors is important when evaluating elderly people with cancer to decide the appropriate treatment. The Oncogeriatric Index (OGI) was developed to predict early death (in 6 months) among elderly people with cancer, based on the Karnofsky Performance Status Scale, the Mini Nutritional Assessment and the Charlson Comorbidity Index. OBJECTIVES: To temporarily validate the OGI.Methods: We used a prospective cohort of cancer patients aged 60 or + years for GA n 605 (2015-2017) [training set]; 2016–2017: n 291 [validation set]) was performed during a six-month follow-up. Epidemiologic data and CGA (using 12 scales) before oncologic treatment were collected. The outcome was ED (within first 180 days). Cox’s proportional hazards model was used for the selection of prognostic factors. A prognostic score, the Onco Geriatric Index (OGI), was constituted of the number of abnormal CGA scales. Overall survival was estimated using the Kaplan–Meier method, and survival curves were compared using the log rank test. Predictive performance (calibration and discrimination) was determined. Results: There were 41 deaths among the 291 admitted patients. Patients who had three altered scales had 23.5 times higher risk of dying, adjusted for age, primary site of cancer and tumor staging (HR = 23.5, 95% CI 7.0-78.4, p < 0.001); those with two, 6.9 times (HR = 6.8, 95% CI 2.4-40.1, p < 0.001); and those with one, 3.1 fold (HR = 3.1, 95% CI 1.2-7.9, p = 0.020). The numbers of deaths predicted by the OGI were similar to those occurred, as well as a 6-month overlap of survival curves for each of the groups in the derivation and validation cohort, demonstrating that this prognostic model had an adequate predictive performance. Conclusions: Geriatric Index (OGI) is valid to evaluate elderly people with cancer in order to identify those at higher risk for early death.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2018 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Patient and Survivor Care

Track

Patient and Survivor Care

Sub Track

Geriatric Oncology

Citation

J Clin Oncol 36, 2018 (suppl; abstr 10049)

DOI

10.1200/JCO.2018.36.15_suppl.10049

Abstract #

10049

Poster Bd #

37

Abstract Disclosures

Similar Abstracts

First Author: Davide Bimbatti

Abstract

2024 ASCO Gastrointestinal Cancers Symposium

Prognostic factors for GEM + nab-PTX combination therapy in elderly patients with pancreatic cancer.

First Author: Kazuki Watabe

First Author: Jurema Telles O Lima